Salvadori M, Rosso G. Update on the gut microbiome in health and diseases. World J Methodol 2024; 14(1): 89196 [PMID: 38577200 DOI: 10.5662/wjm.v14.i1.89196]
Corresponding Author of This Article
Maurizio Salvadori, MD, Professor, Department of Renal Transplantation, Careggi University Hospital, Viale Pieraccini 18, Florence 50139, Tuscany, Italy. maurizio.salvadori1@gmail.com
Research Domain of This Article
Medicine, General & Internal
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Polyamines include putrescine, spermidine and spermine
Sustaining the high proliferation rate of intestinal epithelial cells enhances intestinal barrier integrity and enhances the systematic adaptive immune system
Suppression of colonic inflammation; Decreased innate immune response to microbial stimulation; Protection from allergic airway inflammation; Improvements in insulin sensitivity and weight control in obese mice
Maintenance of host-microbe homeostasis at mucosal surfaces via IL-22; Increased barrier function; Modulation of host metabolism
Indole-3-aldehyde
Tryptophan metabolism
Lactobacillus
Maintenance of mucosal homeostasis and intestinal barrier function via increased IL-22 production; Protection against intestinal inflammation in mouse models of colitis
Indole-3-propionate
Tryptophan metabolism
Clostridium sporogenes
Maintenance of intestinal barrier function and mucosal homeostasis; Increased production of antioxidant and neuroprotectant products
10-hydroxy-cis-12-octadecoate
Linoleic acid derivative (lipid metabolism)
Lactobacillus
Maintenance of intestinal barrier function; Decreased inflammation; Increased intestinal IgA production
Table 5 Some examples of potentially harmful gut microbiota bacterial species
Bacteria
Associated physiologic changes
Associated diseases states
Bacteroides
Activate CD4+ T cells
Increased with animal-based diet; Increased in obesity
Bilophila
Promote pro-inflammatory immunity
Increased in colitis; Decreased in autism
Clostridium
Promote generation Th17 cells
Increased after smoke exposure; Increased in autism and Rett syndrome; Positive correlation with plasma insulin and weight gain; Increased in type 2 diabetes; Clostridium perfrigens increased in old age
Escherichia coli
TLR activation
Increased in inflammatory bowel disease; Increased in type 2 diabetes
Neisseria
Sugar fermentation
Only two species are pathogenic: Neisseria meningitides and Neisseria gonorrhoeae
Table 6 Diseases associated with gut microbiota abnormalities
Disease
Features
Irritable bowel syndrome
An abundance of Firmicutes and a decrease of Bacteroidetes
Type I diabetes
In genetically predisposed individuals, autoimmune against pancreatic β-cells. Deficient development or alteration of the microbiota may contribute to dysfunctional immunity with the devastation of autoimmune β-cells and increased leakiness of the intestinal barrier. Variability of microbiomes reduced
Asthma
Outbreaks of Chlamidophila pneumonia during bronchitis and pneumonia development affect the airway microbiome. Gut microbiota is influenced by the introduction of microbiota to the environment, particularly in early life, which helps immune function growth and the development of defending against allergic sensitization
Food-borne pathogens and food poisoning
Opportunistic pathogens (Campylobacter, Salmonella, Escherichia coli, Shigella) disturb the microbiome’s balance leading to dysbiosis
Malnutrition
Decrease or missing species that either process food categories efficiently or produce vitamins may reduce the absorption of nutrients. An overabundance of Enetrobacteriaceae can lead to epithelial damage, diarrhea, and limited absorption of nutrients
Depression
In physiologic system, Bifidobacterium infantis, generally found in infants’ gastrointestinal tract and administered probiotic drugs, can have antidepressant effects
Anxiety
Oral administration of Campylobacter jejuni subclinical doses in murine models induced anxiety like behavior without stimulating immunity
Citation: Salvadori M, Rosso G. Update on the gut microbiome in health and diseases. World J Methodol 2024; 14(1): 89196